EDGAR Filing Documents for 0001104659-23-081319

Form 424B4 - Prospectus [Rule 424(b)(4)]:

SEC Accession No. 0001104659-23-081319

Filing Date

2023-07-17

Accepted

2023-07-14 18:56:33

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B4	tm237052-16_424b4.htm	424B4	3454737
2	GRAPHIC	lg_sagimet-4c.jpg	GRAPHIC	40042
3	GRAPHIC	bc_weekdosing-4c.jpg	GRAPHIC	88246
4	GRAPHIC	bc_pipeline01-4c.jpg	GRAPHIC	150781
5	GRAPHIC	fc_overview-4c.jpg	GRAPHIC	97317
6	GRAPHIC	fc_patients-4c.jpg	GRAPHIC	148180
7	GRAPHIC	fc_excessliver-4c.jpg	GRAPHIC	83370
8	GRAPHIC	fc_denifanstat-4c.jpg	GRAPHIC	83698
9	GRAPHIC	fc_pathogenesis-4c.jpg	GRAPHIC	177297
10	GRAPHIC	fc_clinicaltrial4c.jpg	GRAPHIC	66855
11	GRAPHIC	bc_liverfatbio-4c.jpg	GRAPHIC	96998
12	GRAPHIC	bc_inflammation-4c.jpg	GRAPHIC	85489
13	GRAPHIC	bc_fibrosiss-4c.jpg	GRAPHIC	55214
14	GRAPHIC	fc_metabolic-4c.jpg	GRAPHIC	58576
15	GRAPHIC	fc_clinicaltrial-4c.jpg	GRAPHIC	73450
16	GRAPHIC	bc_biomarkerimaging-4c.jpg	GRAPHIC	75573
17	GRAPHIC	ph_denifanstat-4c.jpg	GRAPHIC	174205
18	GRAPHIC	bc_lipotoxicity-4c.jpg	GRAPHIC	115107
19	GRAPHIC	bc_fibrosisbio-4c.jpg	GRAPHIC	53177
20	GRAPHIC	bc_lipidbio-4c.jpg	GRAPHIC	56927
21	GRAPHIC	tb_treatment-4c.jpg	GRAPHIC	142382
22	GRAPHIC	bc_denifanstat-4c.jpg	GRAPHIC	31490
23	GRAPHIC	tb_fibrogenic-4c.jpg	GRAPHIC	67467
24	GRAPHIC	bc_collagen-4c.jpg	GRAPHIC	126647
25	GRAPHIC	fc_precision-4c.jpg	GRAPHIC	116752
26	GRAPHIC	bc_tripalmitin-4c.jpg	GRAPHIC	26859
27	GRAPHIC	lc_predictive-4c.jpg	GRAPHIC	53447
28	GRAPHIC	fc_diseaserationale-4c.jpg	GRAPHIC	142821
29	GRAPHIC	tb_oncology-4c.jpg	GRAPHIC	127756
30	GRAPHIC	bc_solidtumors-4c.jpg	GRAPHIC	88587
	Complete submission text file	0001104659-23-081319.txt		7080553

Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402

Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600

Sagimet Biosciences Inc. (Filer) CIK: 0001400118 (see all company filings)